Al-Jada Health Center Continues Providing Medical Services to Beneficiaries in Hajjah Governorate    Saudi Press: Saudi Arabia Exerts Unremitting Efforts for Sustainability of Oil Market Balance    Number of UN Humanitarian Organization Officials Thanks Saudi Arabia for Its Support to Yemen    KSrelief launches 2nd phase of Taiz prosthetic center    Corona vaccine for every American by April: Trump    No evidence of Hezbollah explosives stores: France    Weather Forecast for Saturday    GCC Secretary General Welcomes Statement Issued by Ministerial Group on Yemen    Trump awards Kuwaiti emir 'prestigious' decoration    Britain entering second wave of coronavirus, Johnson warns    S. Korea Urges ADB to Step Up Efforts for Transformation in Post-Pandemic Era    Entrepreneurs can now set up free online stores    KSrelief inaugurates final stage of dialysis center at Beirut's Al-Makassed Hospital    Wydad appeal over CAF 2019 Champions' final dismissed by CAS    Invesco's multi-factor strategy helps manage climate risk in investment portfolios    SWIFT announces a new strategy for instant, frictionless payments and securities processing    Nazaha probes 374 people for graft Crown Prince sends appreciation letter to Authority's employees, calling them 'knights of this fierce fight against corruption'    Worldwide coronavirus cases cross 30.26 million, death toll at 945,533    Riyadh rises 18 places to 53rd rank in global list of smart cities    ECZA Concludes Golden Sponsor Role for New World Model    King Salman, Crown Prince congratulate Nepalese president on Constitution Day    Ulissi cruises to sprint victory in Luxembourg Italian reclaims race leadership heading into final day    Saudi Hospital Obtains HACCP Certification    EU wants to buy more COVID vaccines    Global Coronavirus Cases Surpass 30 Million, Reuters tally    Gaviria wins Giro della Toscana; Philipsen 2nd in Luxembourg    Zahraa, a Saudi graduate in media, follows her passion in car décor job    Diabetes in Saudi Arabia: Prevalence, Prevention, and Progress    ITF unveils a historic rebrand of Fed Cup The global women's team tournament is renamed the 'Billie Jean King Cup by BNP Paribas'    Ace Travel to sponsor JCA Saudi Cup    GFH supports children with cancer's educational achievements    Completion of the Privatization of the First & Third Flour Milling Companies    Arab stars to feature in 5-day 90th National Day concerts    Saudi Youths Transfer Saudi Arabia's Culture via Animation Production    Saudi Scholarship Program to Promote Football Talents, abroad, Co-sign Accord with Spanish Real Sociedad    French Open to allow 11,500 fans per day between the three show courts    Saudi Films' Festival virtual Events Continued    Saudi Taekwondo Team Win 3-Medal, in Arab 1st virtually Held Championships    Saudi Films' Festival Events Continue, amid Wide-Scale Cultural Participation    Mediation center contributes to 22% decrease in divorces    Saudi Films' Festival Kicked off, in its 6th Edition    Saudi woman seeks to restrain wealthy hubby from remarrying    India's top minister Amit Shah tests positive for coronavirus    Azra Aly, South African pilgrim: ‘The beginning of the rest of my life'    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    Senior Scholars Council Issues Decision No. 246 Regarding Attendance of Friday Prayer and Prayers at Mosques in a Case of Spread of Epidemic or Fear of its Spread    Custodian of the Two Holy Mosques Addresses Citizens and Muslims on Eid Al-Fitr    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Julphar announces 90% increase in sales in comparison to Q2 2019
Published in The Saudi Gazette on 13 - 08 - 2020

Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, has reported its financial results for the second quarter of 2020.
As of June 2020, the company generated AED169.7 million in sales representing a 90% increase in comparison to Q2 2019, owing to the lift of the temporary suspension on export of products to Kuwait, Saudi Arabia, Oman and Bahrain earlier this year and growth in several of its core markets.
In addition, Julphar has announced a net loss of AED25.6 million which is an improvement of 73% versus Q2 2019, achieved due to the increase in net sales, expense reduction and gross margin improvement.
In July, Julphar successfully restructured its capital base following the completion of the rights issue which was oversubscribed by 2.3 times indicating strong investor confidence.
Sheikh Saqer Humaid Al Qasimi, chairman of the Board, Julphar, said: "It is deeply encouraging to witness the improvement in sales and reduction of losses over the last quarter, which is testament to the resilience of the company's business model and exemplary vision.
"The progress we have achieved is instrumental to sustain our 40-year legacy of providing advanced healthcare solutions globally."
Dr. Essam Farouk, chief executive officer of Julphar, said: "Following the successful capital restructuring and the return to Saudi Arabia and all GCC markets, we are progressing on plan towards achieving profitability and to further enhance our business performance.
"By maintaining the course in our transformation, we continue our mission to offer full disease management to the millions of people that we proudly serve locally, regionally, and globally."
In 2020, Julphar announced the relaunch of over 80 products in Saudi Arabia, Kuwait, Bahrain, and Oman after the confirmation of its full compliance with Good Manufacturing Practices (GMP) through an inspection conducted by the Gulf Health Council (GHC) and the Saudi Food and Drug Authority (SFDA).
The company has also made strategic senior C-suite appointments to deliver a greater impact in the 50 markets that Julphar operates in.
The future plans of Julphar focus on the strategic areas of the business as the company divests from non-core subsidiaries, regains market position in Saudi Arabia, Kuwait and Oman, continues to build new alliances and partnerships to strengthen the company's product portfolio, launch new products in core therapeutic areas and invest in capital expenditure to improve operations efficiency. — SG

Clic here to read the story from its source.